Search Results - "Murakami, Shigekazu"
-
1
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas
Published in Developmental cell (07-10-2019)“…Employing inducible genetically engineered and orthotopic mouse models, we demonstrate a key role for transcriptional regulator Yap in maintenance of…”
Get full text
Journal Article -
2
SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell‐Like Properties and Are Potential Differentiation Therapy Targets
Published in Stem cells (Dayton, Ohio) (01-09-2015)“…The acquisition of stemness is a hallmark of aggressive human hepatocellular carcinoma (hHCC). The stem cell marker OCT4 is frequently expressed in HCCs, and…”
Get full text
Journal Article -
3
Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas
Published in Nature communications (15-03-2023)“…Lineage plasticity has been proposed as a major source of intratumoral heterogeneity and therapeutic resistance. Here, by employing an inducible genetic…”
Get full text
Journal Article -
4
PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer
Published in Cell reports (Cambridge) (28-05-2024)“…Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis due to therapeutic resistance. We show that PDAC cells undergo global epigenetic…”
Get full text
Journal Article -
5
SGF29 and Sry pathway in hepatocarcinogenesis
Published in World journal of biological chemistry (26-08-2015)“…Deregulated c-Myc expression is a hallmark of many human cancers. We have recently identified a role of mammalian homolog of yeast…”
Get full text
Journal Article -
6
The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity
Published in Oncogene (01-04-2019)“…The Hippo-Yap/Taz pathway, originally identified as a central developmental regulator of organ size, has been found perturbed in many types of human tumors,…”
Get full text
Journal Article -
7
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma
Published in Oncogene (02-03-2017)“…Pancreatic ductal adenocarcinoma (PDAC) is characterized by a high degree of inflammation and profound immune suppression. Here we identify Yes-associated…”
Get full text
Journal Article